Please note that the sessions and live Q&A’s during the SIOP 2020 Virtual Congress will take place according to Eastern Daylight Time (EDT/UTC-4).
Thursday, October 15th, 2020
Session Title To Be Announced
SYMPOSIUM ORGANIZED AND SPONSORED BY EUSAPharma
This session is not included in main conference CME/CPD credit
07:30-08:30 EDT
Chair: To be announced
TIMING, DURATION OF LECTURES, SPEAKERS – To be announced
Q&A SESSION – To be announced
All Faculty
Improving outcomes for all patients with ALL – can collaboration between adult and pediatric treaters make a difference in patient outcomes
SYMPOSIUM ORGANIZED AND SPONSORED BY SERVIER
This session is not included in main conference CME/CPD credit
09:40-12:00 EDT
Chairs: Dan Douer & Scott Howard
TIMING, DURATION OF LECTURES, SPEAKERS – To be announced
Q&A SESSION – To be announced
All Faculty
Education – On the Horizon: Immunotherapy Strategies for Relapsed/Refractory High-Risk Neuroblastoma
SYMPOSIUM ORGANIZED AND SPONSORED BY Y-mAbs Therapeutics & Ology Medical
This session is not included in main conference CME/CPD credit
12:00-13:30 EDT
Chair: Susan Cohn, USA
12:00 – 12:10: WELCOME AND INTRODUCTION
Susan Cohn, USA
12:10 – 12:35: Unmet needs in R/R high-risk neuroblastoma: rising to the challenge
Susan Cohn, USA
12:35 – 13:00: Targeted immunotherapy approaches in the R/R setting: evidence and perspectives
Daniel Morgenstern, Canada
13:00 – 13:25: Optimizing clinical management and treatment outcomes: a multidisciplinary approach
Jaume Mora, Spain
13:25 – 13:30: LIVE SUMMARY SESSION
All Faculty, the discussion will continue as Meet the Experts Q&A in the chat room until 14:00
Friday, October 16th, 2020
Epigenetic Modifiers in Pediatric Oncology
SYMPOSIUM ORGANIZED AND SPONSORED BY Bristol-Meyers Squibb
This session is not included in main conference CME/CPD credit
07:30-08:30 EDT
Chair: Eric Bouffet, Canada
07:30 – 07:35 OPENING REMARKS
Eric Bouffet, Canada
07:35 – 07:50 BET Inhibition
Franck Bourdeaut, France
07:50 – 08:05 HDAC Inhibition
To be Confirmed
08:05 – 08:20 Menin Pathway
Michel Zwaan, Netherlands
08:20 – 08:30 Q&A SESSION
All Faculty
Temozolomide in the treatment of relapsed or refractory pediatric tumors: development of a ready to use and taste-masked oral suspension adapted to children
PRODUCT THEATRE SESSION ORGANIZED AND SPONSORED BY Orphelia Pharma
This session is not included in main conference CME/CPD credit
09:15-09:35 EDT
Chair: To be announced
TIMINGS & LECTURE TITLES TO BE ANNOUNCED
Dr Lucas Moreno, title to be announced
Dr Dominique Valteau-Couanet, title to be announced
Dr Caroline Lemarchand, title to be announced